189 related articles for article (PubMed ID: 31759108)
1. pH-responsive chimeric liposomes: From nanotechnology to biological assessment.
Naziris N; Saitta F; Chrysostomou V; Libera M; Trzebicka B; Fessas D; Pispas S; Demetzos C
Int J Pharm; 2020 Jan; 574():118849. PubMed ID: 31759108
[TBL] [Abstract][Full Text] [Related]
2. Development and Evaluation of Stimuli-Responsive Chimeric Nanostructures.
Naziris N; Pippa N; Stellas D; Chrysostomou V; Pispas S; Demetzos C; Libera M; Trzebicka B
AAPS PharmSciTech; 2018 Oct; 19(7):2971-2989. PubMed ID: 30030723
[TBL] [Abstract][Full Text] [Related]
3. Chimeric Stimuli-Responsive Liposomes as Nanocarriers for the Delivery of the Anti-Glioma Agent TRAM-34.
Naziris N; Pippa N; Sereti E; Chrysostomou V; Kędzierska M; Kajdanek J; Ionov M; Miłowska K; Balcerzak Ł; Garofalo S; Limatola C; Pispas S; Dimas K; Bryszewska M; Demetzos C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200955
[TBL] [Abstract][Full Text] [Related]
4. Thermoresponsive chimeric nanocarriers as drug delivery systems.
Naziris N; Pippa N; Skandalis A; Miłowska K; Balcerzak Ł; Pispas S; Bryszewska M; Demetzos C
Colloids Surf B Biointerfaces; 2021 Dec; 208():112141. PubMed ID: 34624599
[TBL] [Abstract][Full Text] [Related]
5. Calorimetric study on pH-responsive block copolymer grafted lipid bilayers: rational design and development of liposomes.
Pippa N; Chountoulesi M; Kyrili A; Meristoudi A; Pispas S; Demetzos C
J Liposome Res; 2016 Sep; 26(3):211-20. PubMed ID: 26364717
[TBL] [Abstract][Full Text] [Related]
6. Design and development of pH-responsive HSPC:C
Naziris N; Pippa N; Meristoudi A; Pispas S; Demetzos C
J Liposome Res; 2017 Jun; 27(2):108-117. PubMed ID: 27558454
[TBL] [Abstract][Full Text] [Related]
7. Association of the Thermodynamics with the Functionality of Thermoresponsive Chimeric Nanosystems.
Naziris N; Skandalis A; Mavromoustakos T; Pispas S; Demetzos C
Methods Mol Biol; 2021; 2207():221-233. PubMed ID: 33113139
[TBL] [Abstract][Full Text] [Related]
8. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.
Abri Aghdam M; Bagheri R; Mosafer J; Baradaran B; Hashemzaei M; Baghbanzadeh A; de la Guardia M; Mokhtarzadeh A
J Control Release; 2019 Dec; 315():1-22. PubMed ID: 31647978
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of PEGylated δ-decalactone into lipid bilayers: thermodynamic study and chimeric liposomes development.
Pippa N; Skouras A; Naziris N; Biondo F; Tiboni M; Katifelis H; Gazouli M; Demetzos C; Casettari L
J Liposome Res; 2020 Sep; 30(3):209-217. PubMed ID: 31146618
[TBL] [Abstract][Full Text] [Related]
10. Hydrazone linkages in pH responsive drug delivery systems.
Sonawane SJ; Kalhapure RS; Govender T
Eur J Pharm Sci; 2017 Mar; 99():45-65. PubMed ID: 27979586
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Vesicular Nanosystems Based on Lipids and Polymers Applied in Therapy, Theranostics, and Cosmetics.
Castro NR; Pinto CSC; Santos EP; Mansur CRE
Crit Rev Ther Drug Carrier Syst; 2020; 37(3):271-303. PubMed ID: 32749140
[TBL] [Abstract][Full Text] [Related]
12. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Rajpoot K
Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
[TBL] [Abstract][Full Text] [Related]
14. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
Ruiz ME; Gantner ME; Talevi A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
[TBL] [Abstract][Full Text] [Related]
15. Block copolymers for drug delivery nano systems (DDnSs).
Kaditi E; Mountrichas G; Pispas S; Demetzos C
Curr Med Chem; 2012; 19(29):5088-100. PubMed ID: 22963634
[TBL] [Abstract][Full Text] [Related]
16. Chimeric liposomes incorporating functional copolymers: preparation and pH/thermo-responsive behaviour in aqueous solutions.
Sentoukas T; Demetzos C; Pispas S
J Liposome Res; 2021 Sep; 31(3):279-290. PubMed ID: 33590785
[TBL] [Abstract][Full Text] [Related]
17. Stimuli-Responsive Polymersomes for Biomedical Applications.
Hu X; Zhang Y; Xie Z; Jing X; Bellotti A; Gu Z
Biomacromolecules; 2017 Mar; 18(3):649-673. PubMed ID: 28212005
[TBL] [Abstract][Full Text] [Related]
18. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-responsive polymersomes as nanocarriers for drug and gene delivery.
Onaca O; Enea R; Hughes DW; Meier W
Macromol Biosci; 2009 Feb; 9(2):129-39. PubMed ID: 19107717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
